Efficacy of thalidomide in the treatment of prurigo nodularis

Acta Dermato-Venereologica

Volumn 91, Issue 3, 2011, Pages 344-345

  Taefehnorooz, Hamid ^a   Truchetet, François ^b   Barbaud, Annick ^a   Schmutz, Jean Luc ^a   Bursztejn, Anne Claire ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b Beauregard Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; THALIDOMIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE DURATION; DIZZINESS; DRUG EFFICACY; DRUG WITHDRAWAL; ELECTROMYOGRAM; FEMALE; FRANCE; HUMAN; LOW DRUG DOSE; MALE; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; PARESTHESIA; PATIENT COMPLIANCE; PERIPHERAL NEUROPATHY; PHOTOTHERAPY; PRIORITY JOURNAL; PRURIGO; PRURIGO NODULARIS; RETROSPECTIVE STUDY; SEDATION; SIDE EFFECT; TREATMENT DURATION;

ADULT; AGED; DERMATOLOGIC AGENTS; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; PRURIGO; RETROSPECTIVE STUDIES; THALIDOMIDE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79955715788     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0997     Document Type: Article

References (8)

1. Alfadley A, Al-Hawsawi K, Thestrup-Pedersen K, Al-Aboud K. Treatment of prurigo nodularis with thalidomide: a case report and review of the literature. Int J Dermatol 2003; 42: 372-375.
2. Sharma NL, Sharma VC, Mahajan VK, Shanker V, Ranjan N, Gupta M. Thalidomide: an experience in therapeutic outcome and adverse reactions. J Dermatolog Treat 2007; 18: 335-340.
3. Herranz P, Pizarro A, De Lucas R, Arribas JR, Garcia-Tobaruela A, Pena JM, et al. Treatment of AIDS-associated prurigo nodularis with thalidomide. Clin Exp Dermatol 1998; 23: 233-235.
4. Lan CC, Lin CL, Wu CS, Chai CY, Chen WT, Chen GS. Treatment of idiopathic prurigo nodularis in Taiwanese patients with low-dose thalidomide. J Dermatol 2007; 34: 237-242.
5. Doherty SD, Hsu S. A case series of 48 patients treated with thalidomide. J Drugs Dermatol 2008; 7: 769-773.
6. Orlando A, Renna S, Cottone M. Prurigo nodularis of Hyde treated with low-dose thalidomide. Eur Rev Med Pharmacol Sci 2009; 13: 141-145.
7. Wulff CH, Høyer H, Asboe-Hansen G, Brodthagen H. Development of polyneuropathy during thalidomide therapy. Br J Dermatol 1985; 112: 475-480.
8. Aronson IK, Yu R, West DP, Van den Broek H, Antel J. Thalidomide-induced peripheral neuropathy. Effect of serum factor on nerve cultures. Arch Dermatol 1984; 120: 1466-1470.